We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+1.67%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$163M
AUM Growth
-$6.83M
(-4%)
Cap. Flow
-$37.1M
Cap. Flow
% of AUM
-22.75%
Top 10 Holdings %
Top 10 Hldgs %
30.94%
Holding
192
New
47
Increased
35
Reduced
23
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adtran
ADTN
|
+$6.46M |
| 2 |
indie Semiconductor
INDI
|
+$2.74M |
| 3 |
Silicom
SILC
|
+$2.7M |
| 4 |
SEV
Sono Group N.V. Common Shares
SEV
|
+$2.6M |
| 5 |
TELA Bio
TELA
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBE
Cyberoptics Corp
CYBE
|
+$3.74M |
| 2 |
CTO
CTO Realty Growth
CTO
|
+$865K |
| 3 |
SCPH
scPharmaceuticals
SCPH
|
+$788K |
| 4 |
A10 Networks
ATEN
|
+$680K |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$640K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 15.13% |
| 3 | Consumer Discretionary | 5.61% |
| 4 | Financials | 5.45% |
| 5 | Materials | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Carvana
CVNA
$43.3B
| $6.36M | 3.9% |
1,567,435
| – | – |
|
|
2
Adtran
ADTN
$798M
| $5.8M | 3.55% |
+296,241
| New | +$6.46M |
|
|
AVEO
3
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $5.64M | 3.45% |
685,026
-31,410
| -4% | -$241K |
|
4
Materion
MTRN
$5.01B
| $4.81M | 2.94% |
60,079
+24,953
| +71% | +$2.06M |
|
|
DZSI
5
DELISTED
DZS Inc. Common Stock
DZSI
| $4.67M | 2.86% |
413,228
-9,609
| -2% | -$136K |
|
|
TGAN
6
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $4.58M | 2.81% |
911,237
+286,424
| +46% | +$1.41M |
|
7
Aviat Networks
AVNW
$262M
| $3.77M | 2.31% |
137,756
-500
| -0.4% | -$15K |
|
|
8
TELA Bio
TELA
$30.9M
| $3.24M | 1.98% |
380,196
+267,184
| +236% | +$2.22M |
|
|
9
indie Semiconductor
INDI
$733M
| $2.71M | 1.66% |
+370,699
| New | +$2.74M |
|
10
ANI Pharmaceuticals
ANIP
$1.77B
| $2.52M | 1.54% |
78,251
+17,420
| +29% | +$596K |
|
|
PRTK
11
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.49M | 1.53% |
969,698
| – | – |
|
|
12
Silicom
SILC
$228M
| $2.48M | 1.52% |
+70,146
| New | +$2.7M |
|
13
Franklin Covey
FC
$233M
| $2.35M | 1.44% |
51,861
-2,859
| -5% | -$141K |
|
|
CAMP
14
DELISTED
CalAmp Corp.
CAMP
| $2.3M | 1.41% |
26,024
+652
| +3% | +$74.2K |
|
|
SEV
15
DELISTED
Sono Group N.V. Common Shares
SEV
| $2.22M | 1.36% |
+874,813
| New | +$2.6M |
|
16
Silicon Motion
SIMO
$9.19B
| $1.88M | 1.15% |
28,835
| – | – |
|
17
Progressive
PGR
$124B
| $1.86M | 1.14% |
16,021
-2,391
| -13% | -$288K |
|
18
Raymond James Financial
RJF
$32.5B
| $1.79M | 1.1% |
18,151
-2,035
| -10% | -$206K |
|
|
THER
19
DELISTED
THERATECHNOLOGIES INC COM
THER
| $1.76M | 1.08% |
743,423
| – | – |
|
20
Bank of America
BAC
$435B
| $1.7M | 1.04% |
56,195
| – | – |
|
21
Hilton Grand Vacations
HGV
$3.84B
| $1.58M | 0.97% |
47,905
| – | – |
|
22
OneMain Financial
OMF
$6.9B
| $1.56M | 0.95% |
52,755
| – | – |
|
23
Airgain
AIRG
$74.3M
| $1.3M | 0.8% |
180,308
| – | – |
|
24
PUT
iShares S&P 100 ETF
OEF
$19.8B
| $1.27M | 0.78% |
102,500
-101,400
| -50% | -$18.4M |
|
25
Everspin Technologies
MRAM
$354M
| $1.27M | 0.78% |
218,862
-76,431
| -26% | -$487K |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Worth Venture Partners held 192 positions worth $163M, down 4% from $170M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Worth Venture Partners withdrew a net $37.1M in Q3 2022, closing 17 positions and reducing 23 holdings. Its most notable exit was Cyberoptics Corp, an estimated $3.74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Worth Venture Partners opened a new position in Adtran worth $5.8M.
- Worth Venture Partners's largest Q3 2022 buy was Adtran: 296,241 shares worth $5.8M.
- Worth Venture Partners added most to TELA Bio in Q3 2022, an estimated $2.22M increase.
- Worth Venture Partners's biggest Q3 2022 reduction was CTO Realty Growth, cutting an estimated $865K.
- Worth Venture Partners fully exited Cyberoptics Corp in Q3 2022, selling an estimated $3.74M.
- Worth Venture Partners's ten largest holdings make up 31% of its $163M portfolio in Q3 2022.
- Worth Venture Partners opened 47 new positions and closed 17 in Q3 2022.
- Worth Venture Partners's portfolio value fell 4% quarter-over-quarter to $163M.
Based on Worth Venture Partners's 13F filing for Q3 2022, filed 14 Nov 2022.